SCHEMBL6940477

SCHEMBL6940477

CC(C)(C)[Si](C[C@H](CCn1cnc2c(Cl)nc(N)nc21)COCc1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 10/20 0.38
HSP90AA1 P07900 9/20 0.38
HRH4 Q9H3N8 1/20 0.38
HDAC1 Q13547 4/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC6 Q9UBN7 5/20 0.36
HDAC4 P56524 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
PHLPP2 Q6ZVD8 1/20 0.36
ADORA2A P29274 2/20 0.35
TMIGD3 P0DMS9 1/20 0.35
ADORA1 P30542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5962141 1.00 HSP90AB1 (0.38) HSP90AB1HSP90AA1HRH4HDAC1HDAC2
SCHEMBL10510295 0.87 HDAC1 (0.44) HSP90AB1HSP90AA1HRH4HDAC1HDAC2
SCHEMBL1663919 0.84 HDAC1 (0.43) HSP90AB1HSP90AA1HRH4HDAC1HDAC2
SCHEMBL1663924 0.84 HDAC1 (0.43) HSP90AB1HSP90AA1HRH4HDAC1HDAC2
SCHEMBL1663801 0.84 HDAC1 (0.43) HSP90AB1HSP90AA1HRH4HDAC1HDAC2
SCHEMBL8618199 0.75 HSP90AB1 (0.38) HSP90AB1HSP90AA1HDAC1HDAC2HDAC6
SCHEMBL8542896 0.75 HSP90AB1 (0.38) HSP90AB1HSP90AA1HDAC1HDAC2HDAC6
SCHEMBL15496830 0.74 HDAC1 (0.42) HDAC1HDAC2HDAC6HDAC4
SCHEMBL16039115 0.73 HSP90AA1 (0.39) HSP90AB1HSP90AA1HRH4HDAC1HDAC2
SCHEMBL10496728 0.73 DAPK1 (0.49) HRH4HDAC6CYP1A2ADORA2ATMIGD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0822817-B1 USE OF (R)-PENCICLOVIR TRIPHOSPHATE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF VIRAL DISEASES NOVARTIS INT PHARM LTD (BM) 2003-07-23 EP disclosed